Emerging market regulatory staff should take test to level playing field, RAPS

By Natalie Morrison

- Last updated on GMT

RAPS: suggests RAC test for emerging market regulatory staff
Regulatory professionals working for contract research organisations (CROs) in emerging markets could benefit from taking a test to bring them up to par with those in developed countries, according to RAPS.

In its recent Scope of Practice and Compensation report – which surveyed more than 3,000 regulatory workers in 58 countries – the society found that on average staff in charge of trials’ regulatory aspects in established markets like the US or Europe have more experience than those in emerging industries.

Speaking to Outsourcing-Pharma.com, Regulatory Affairs Professionals society (RAPS) executive director Sherry Keramidas said she believes the results boil down to the fact the regulatory professional role is “younger” ​in BRIC countries.

She said however that by taking a simple RAPS test called the RAC (Regulatory Affairs Certification) – a post academic credential for regulatory individuals – professionals could not only gain sponsors’ confidence by proving their knowledge, but could also boost skills by studying for the exam.

“I think it can help to eliviate problems in developing markets for instance with CROs,”​ she said. “It definitely highlights whether the professional has the core competancies and skills.”

Keramidas added that RAPS is currently working with a number of regulators including the World Health Organisation (WHO) and the US Food and Drug Administration (FDA) to boost capabilities in emerging countries, who have shown a big interest in the test.

She said that new developments could include a pre-examination for the RAC, especially for regulatory professionals in areas known to have had compliance issues.

“It may be done in steps, so they would have a pre RAC qualification before they take the actual RAC,”​ she told us.

Related news

Related products

show more

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us


View more